Daito Pharmaceutical Co., Ltd.
Research Daito Pharmaceutical Co., Ltd. (4577.T) on Bullrun: market cap JPY 38.74B, P/E 13.0, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4577.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 38.74B
- P/E13.0
- Dividend yield3.0%
- Financial periodFY2026
- RevenueJPY 50.65B
- Revenue growth0.0%
- Net incomeJPY 3.16B
- Free cash flowJPY 4.16B
- Gross margin19.5%
Valuation Snapshot
latest market cap is JPY 38.74B; P/E is 13.0; dividend yield is 3.0%.
Peer valuation comparison
Latest P/E is 12.99x versus a Healthcare sector median of 21.69x (40.1% below).
Latest dividend yield is 2.96% versus a Healthcare sector median of 2.41% (22.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 50.65B | JPY 3.16B | JPY 4.16B | 19.5% | 107.49 | JPY 954.00M | JPY 9.29B | JPY 52.89B |
| FY2025 | JPY 50.64B | JPY 1.91B | -JPY 1.20B | 17.1% | 62.74 | JPY 2.21B | JPY 11.89B | JPY 52.00B |
| FY2024 | JPY 46.90B | JPY 3.30B | -JPY 1.09B | 21.0% | 105 | JPY 2.73B | JPY 8.72B | JPY 52.07B |
| FY2023 | JPY 45.10B | JPY 3.60B | -JPY 1.40B | 22.9% | 113.71 | JPY 3.61B | JPY 4.89B | JPY 50.67B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 38.74B | 13.0 | 3.3% | 45 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 45 JPY, yield 3.0%.
| Year | Dividends/share |
|---|---|
| FY2026 | 20 JPY |
| FY2025 | 37.5 JPY |
| FY2024 | 32.5 JPY |
| FY2023 | 28.64 JPY |
| FY2022 | 29.55 JPY |
About Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients (APIs) for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company also engages in wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. Daito Pharmaceutical Co., Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Daito Pharmaceutical Co., Ltd.'s market cap?
Daito Pharmaceutical Co., Ltd.'s market capitalization is JPY 38.74B.
What is Daito Pharmaceutical Co., Ltd.'s P/E ratio?
Daito Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 13.0.
Does Daito Pharmaceutical Co., Ltd. pay a dividend?
Daito Pharmaceutical Co., Ltd. has a dividend yield of 3.0%.
What does Daito Pharmaceutical Co., Ltd. do?
Daito Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients (APIs) for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company also engages in wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. Daito Pharmaceutical Co., Ltd.